Pharma Supply Chain ABM

Powered by Simudyne
DEMOIllustrative model — not for clinical, procurement, or regulatory decisions.

Vulnerability Map

Disruption impact analysis based on 30-seed Monte Carlo • AI Min SL: 55.7% • No-AI Min SL: 53.0%

Network Topology — Disruption Impact
Tier 3
1
2
3
Tier 2
1
2
3
4
3 hit
Tier 1
1
2
3
4
5
2 hit
Manufacturing
1
2
3
1 hit
Distribution
1
2
3
4
1 hit
Pharmacy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
criticalhighmediumlow
Scenario Impact (SL Drop)
Geographic Concentration
Critical Points of Failure
Tier 23 agents disrupted
Cascade Impact Score by Tier